// App-Quantinova.ai

3381 : Outcome After First Relapse Or Refractory Acute Lymphoblastic Leukemia In Children From 1996 To 2011 Comparison Of Two Different Treatment Strategies

Researchers

Presenter

  • Francesco Ceppi

Principal Investigators

  • Michel Duval

  • Caroline Laverdiere

  • Jean-Marie Leclerc

  • Yveline Delvas

  • Sonia Cellot

  • Pierre Teira

  • Henrique Bittencourt

Medical Centers

  • Hematology-Oncology Division, Charles Bruneau Cancer Center, Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada

  • Hematology-Oncology, Ste-Justine Hospital, University of Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • White Blood Cell

Drug/Treatment

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim